Ftse Mib
37.675,40
-1,44%
DAX
22.328,77
-1,23%
S&P 500
5.571,83
-0,76%
NASDAQ
17.367,93
-0,57%
Bitcoin
81.809,34
4,25%
Pepperstone
Advertisement
Registration Strip Icon for default Registrati gratuitamente per ottenere quotazioni in tempo reale, grafici interattivi, flusso di opzioni in tempo reale e altro ancora.
Registrati

Quotazioni in diretta

Non abbiamo trovato risultati per:
Assicurati di aver scritto correttamente o prova ad allargare la ricerca.

Più Attivi

Toplist

Sembra che tu non sia connesso.
Clicca il pulsante qui sotto per accedere e visualizzare la tua cronologia recente.

Registrati

Sei già registrato? Accedi

Pepperstone

Inizia Ora

Pepperstone
Home Investire Azioni U.S.A. NASDAQ Femasys Inc (FEMY) Femasys Inc (FEMY) Notizie

Femasys Inc

FEMY
1,4276
0,0276 (1,97%)
Ultimo aggiornamento: 18:50:22
Dati in Delay di 15 minuti
Borsa: NASDAQ
Tipo: Azione
Valuta: USD

Ultime notizie

Data Ora Fonte Titolo
27/2/202502:10EDGAR2Form SCHEDULE 13G - Statement of Beneficial Ownership by..
25/2/202515:20GLOBEFemasys Announces Peer-Reviewed Publication of Positive..
11/2/202515:00GLOBEFemasys Announces UK Regulatory Approvals for FemaSeed® for..
04/2/202515:00GLOBEFemasys Announces Israeli Regulatory Approvals for FemaSeed®..
31/1/202501:33EDGAR2Form 4 - Statement of changes in beneficial ownership of..
31/1/202501:33EDGAR2Form 4 - Statement of changes in beneficial ownership of..
30/1/202514:30GLOBEFemasys Announces Notices of Intention to Grant for Two New..
16/1/202514:30GLOBEFemasys Announces Notice of Allowance for New U.S. Patent..
03/12/202415:00GLOBEFemasys Announces Partnership with HRC Fertility, Esteemed..
26/11/202414:30GLOBEFemasys Announces Peer-Reviewed Publication of Positive Data..
12/11/202422:01EDGAR2Form 8-K/A - Current report: [Amend]
12/11/202414:51EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
12/11/202414:30GLOBEFemasys Announces Financial Results for Quarter Ended..
07/11/202414:30GLOBEFemasys to Exhibit at the Annual AAGL 2024 Global Conference
01/11/202413:30GLOBEFemasys Announces Issued U.S. Patent Covering..
30/10/202414:00GLOBEFemasys Announces Partnership with Boston IVF, Prominent..
29/10/202413:30EDGAR2Form 8-K - Current report
10/10/202414:30GLOBEFemasys to Exhibit at ASRM 2024 and Participate in the..
08/10/202414:30GLOBEFemasys to Participate in a Fireside Chat at the 2024 Maxim..
02/10/202414:30GLOBEFemasys Receives Second Order from Spain Partners After..
18/9/202414:30GLOBEFemasys Announces Infertility Clinic Customers from Coast to..
11/9/202414:38EDGAR2Form 8-K - Current report
11/9/202414:30GLOBEFemasys Secures Strategic Distribution Partnerships for..
09/9/202414:45EDGAR2Form 8-K - Current report
09/9/202414:30GLOBEFemasys Inc. Receives U.S. FDA Clearance to Market FemChec®,..
05/9/202414:30GLOBEFemasys to Exhibit at The Canadian Fertility and Andrology..
03/9/202414:30GLOBEFemasys to Participate in Fireside Chat at the H.C...
30/8/202422:31EDGAR2Form 8-K - Current report
29/8/202415:15EDGAR2Form 8-K - Current report
29/8/202414:30GLOBEFemasys Announces CE Mark and Canadian Approval for FemVue®..
27/8/202414:30GLOBEFemasys Hosts Congresswoman Lucy McBath at Georgia..
08/8/202414:45EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
08/8/202414:35EDGAR2Form 8-K - Current report
08/8/202414:30GLOBEFemasys Announces Financial Results for Quarter Ended June..
15/7/202422:39EDGAR2Form 4 - Statement of changes in beneficial ownership of..
15/7/202422:37EDGAR2Form 4 - Statement of changes in beneficial ownership of..
15/7/202422:34EDGAR2Form 4 - Statement of changes in beneficial ownership of..
15/7/202422:33EDGAR2Form 4 - Statement of changes in beneficial ownership of..
12/7/202422:01EDGAR2Form 8-K - Current report
27/6/202414:30GLOBEFemasys to Participate in European Society of Human..
20/6/202414:49EDGAR2Form 8-K - Current report
20/6/202414:30GLOBEFemasys Receives CE Mark Approval for Four of its Women’s..
07/6/202422:01EDGAR2Form DEF 14A - Other definitive proxy statements
17/5/202414:30GLOBEFemasys CEO and Founder Kathy Lee-Sepsick Meets with the..
16/5/202414:30GLOBEFemasys CEO and Founder Kathy Lee-Sepsick Meets with the..
09/5/202414:40EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
09/5/202414:35EDGAR2Form 8-K - Current report
09/5/202414:30GLOBEFemasys Announces Financial Results for Quarter Ended March..
07/5/202414:30GLOBEFemasys Expands Commercial Management Team with Addition of..
18/4/202414:30GLOBEFemasys CEO and Founder Kathy Lee-Sepsick Meets with Members..
Apertura: 1,40 Min: 1,375 Max: 1,4799
Chiusura: 1,40

La tua Cronologia

NASDAQ
FEMY
Femasys
Delayed Upgrade Clock

Il sito ADVFN Italia è stato realizzato ed è gestito da PRODESFIN su licenza di ADVFN PLC.

PER CONTATTI E PUBBLICITA' SUL SITO CLICCARE QUI

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network

Rimuovi gli annunci

Iscriviti per un'esperienza senza pubblicità

Nessuna pubblicità

Prova adesso

Conserva gli annunci